Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report.
epithelioid angiomyolipoma
everolimus
hemodialysis
mammalian target of rapamycin inhibitors
tuberous sclerosis
Journal
IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
24
04
2019
accepted:
17
06
2019
entrez:
4
8
2020
pubmed:
4
8
2020
medline:
4
8
2020
Statut:
epublish
Résumé
A patient undergoing hemodialysis and being treated with everolimus for metastatic epithelioid angiomyolipoma has never been described in the literature, to our knowledge. A 53-year-old woman who had undergone trans-arterial embolization for epithelioid angiomyolipoma was referred with a chief complaint about right knee pain. Hemodialysis had been started after the embolization. Needle biopsy specimens of tumors obtained from behind the right kidney and in the right femur were diagnosed as epithelioid angiomyolipoma metastases. The patient underwent treatment with everolimus and achieved a partial response after 6 months of treatment without serious adverse events. Everolimus might be effective for patients with metastatic epithelioid angiomyolipoma who are undergoing hemodialysis.
Identifiants
pubmed: 32743437
doi: 10.1002/iju5.12103
pii: IJU512103
pmc: PMC7292099
doi:
Types de publication
Case Reports
Langues
eng
Pagination
279-282Informations de copyright
© 2019 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Clin Oncol. 2010 Feb 10;28(5):835-40
pubmed: 20048174
Clin Ther. 2009 Aug;31(8):1812-9
pubmed: 19808140
Jpn J Clin Oncol. 2011 Jun;41(6):814-6
pubmed: 21415002
Am J Surg Pathol. 2001 Jan;25(1):121-6
pubmed: 11145246
Histopathology. 2009 Nov;55(5):525-34
pubmed: 19912358
Can Urol Assoc J. 2015 Jul-Aug;9(7-8):E542-5
pubmed: 26279736
Int J Urol. 2013 Sep;20(9):938-41
pubmed: 23347205
Lancet. 2013 Mar 9;381(9869):817-24
pubmed: 23312829
Ann Oncol. 2012 Nov;23(11):2992-2993
pubmed: 23071263
Abdom Radiol (NY). 2018 Oct;43(10):2756-2763
pubmed: 29525877
J Med Case Rep. 2013 Apr 29;7:118
pubmed: 23628229
Clin Genitourin Cancer. 2013 Dec;11(4):e1-5
pubmed: 23791549
Int J Urol. 2005 Feb;12(2):204-7
pubmed: 15733117
J Immunother Cancer. 2018 Oct 1;6(1):97
pubmed: 30285856
Am J Surg Pathol. 2010 May;34(5):715-22
pubmed: 20410812